The Trump administration teams up with western allies to bar HuaWei and other Chinese tech firms.

Daisy Harvey

2019-02-02 11:36:00 Sat ET

The Trump administration teams up with western allies to bar HuaWei and other Chinese tech firms from building the 5G high-speed infrastructure due to national economic security concerns. Justice Department unseals a pair of cases against HuaWei. The first indictment accuses HuaWei of trying to steal trade secrets from T-Mobile by promising obscene bonuses to former employees who would collect confidential information on telecom competitors. The second indictment suggests that HuaWei might have worked to skirt U.S. economic sanctions on Iran.

Robert Williams, executive director at Yale Law School and former consultant to the U.S. State Department, suggests that these criminal investigations should not be viewed as part of the Sino-American trade negotiations because the U.S. law enforcement takes place well in advance of bilateral trade discussions. The Trump administration now asks its western allies from Britain and Canada to France and Germany to ban HuaWei and Ant Financial Group from getting access to critical technologies such as 5G high-speed telecom networks, fintech payment solutions, smart sensors, and autonomous robots and vehicles. This case indicates potential fraud on the part of HuaWei CFO and so sends a negative signal that China might rip off American tech firms with chronic trade deficits and tech transfer practices.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More
The Trump team receives a 3.2% first-quarter GDP boost as Federal Reserve halts the next interest rate hike in May 2019.
Olivia London

2019-05-07 09:30:00 Tuesday ET

The Trump team receives a 3.2% first-quarter GDP boost as Federal Reserve halts the next interest rate hike in May 2019.

The Trump team receives a 3.2% first-quarter GDP boost as Fed Chair Jay Powell halts the next interest rate hike in early-May 2019. This smooth upward econo

+See More
Angus Deaton analyzes the correlation between health and wealth in light of the economic origins of inequality worldwide.
James Campbell

2021-05-11 11:34:00 Tuesday ET

Angus Deaton analyzes the correlation between health and wealth in light of the economic origins of inequality worldwide.

Angus Deaton analyzes the correlation between health and wealth in light of the economic origins of inequality worldwide. Angus Deaton (2015)  

+See More
Investing in stocks is the best way for people to become self-made millionaires.
James Campbell

2019-06-25 10:34:00 Tuesday ET

Investing in stocks is the best way for people to become self-made millionaires.

Investing in stocks is the best way for people to become self-made millionaires. A recent Gallup poll indicates that only 37% of young Americans below the a

+See More
There are several highlights from the first news conference after Trump's presidential election victory.
Monica McNeil

2017-01-23 09:30:00 Monday ET

There are several highlights from the first news conference after Trump's presidential election victory.

There are several highlights from the first news conference after Trump's presidential election victory: The Trump administration will repeal-and-

+See More
Sirius XM pays $3.5 billion shares to acquire the music app company Pandora.
Jonah Whanau

2018-09-25 10:35:00 Tuesday ET

Sirius XM pays $3.5 billion shares to acquire the music app company Pandora.

Sirius XM pays $3.5 billion shares to acquire the music app company Pandora. This acquisition would form the largest audio entertainment company worldwide.

+See More
Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.
Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More